BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3375549)

  • 1. A rapid in vitro assay for predicting thermochemosensitivity of human cancer: comparison with clonogenic assay.
    Yamada K; Neumann HA; Fiebig HH; Engelhardt R; Tokita H
    Recent Results Cancer Res; 1988; 107():177-83. PubMed ID: 3375549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the sensitivity of human cancers to combined chemotherapy and hyperthermia.
    Yamada K; Neumann HA; Fiebig HH; Engelhardt R; Tokita H
    Recent Results Cancer Res; 1988; 109():250-7. PubMed ID: 3175296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictability of response to clinical thermochemotherapy by the clonogenic assay.
    Mann BD; Storm FK; Morton DL; Bertelsen CA; Korn EL; Kaiser LR; Kern DH
    Cancer; 1983 Oct; 52(8):1389-94. PubMed ID: 6616404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancers, measured by the human tumor clonogenic assay.
    Murakami A; Koga S; Maeta M
    Oncology; 1988; 45(3):236-41. PubMed ID: 3368200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the chemosensitivity test by human tumor clonogenic assay and subrenal capsule assay].
    Terashima M
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1554-64. PubMed ID: 3431536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human clonogenic tumor cells.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):515-23. PubMed ID: 2988968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of pulse and continuous exposure in human tumor clonogenic assay.
    Kanzawa F; Matsushima Y; Chiang CD; Nakano H; Nakagawa K; Takahashi H; Sasaki Y; Saijo N
    J Pharmacobiodyn; 1987 Sep; 10(9):449-51. PubMed ID: 3437386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
    Kanzawa F; Matsushima Y; Hoshi A; Shimizu E; Saijo N; Miyazawa N
    Invest New Drugs; 1985; 3(4):341-7. PubMed ID: 3003004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonogenic cell assay for carcinoma of the lung.
    Kanzawa F; Hoshi A; Shimizu E; Saijo N; Miyazawa N; Shimabukuro Z
    Gan; 1984 Jan; 75(1):81-8. PubMed ID: 6327452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clonogenic assay with human tumor xenografts: evaluation, predictive value and application for drug screening.
    Berger DP; Henss H; Winterhalter BR; Fiebig HH
    Ann Oncol; 1990 Sep; 1(5):333-41. PubMed ID: 2261375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of quinocarmycin against carcinoma of the lung in human tumor clonogenic assay.
    Chiang CD; Kanzawa F; Matsushima Y; Nakano H; Nakagawa K; Takahashi H; Terada M; Morinaga S; Tsuchiya R; Sasaki Y
    J Pharmacobiodyn; 1987 Sep; 10(9):431-5. PubMed ID: 3437383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.
    Aschele C; Romanini A; Nicolin A; Rosso R; Sobrero A
    Anticancer Res; 1990; 10(3):759-64. PubMed ID: 2195987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test].
    Gohji K; Okada Y; Hamami G; Kamidono S; Ishigami J; Murao S; Aogauchi R; Maeda S; Sugiyama T
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1294-300. PubMed ID: 2408580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of drug sensitivity tests--usefulness of subrenal capsule assay (SRC)].
    Eto H; Gohji K; Ishikawa J; Itani A; Hamami G; Kamidono S; Tadera S; Yamanaka N
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):143-9. PubMed ID: 3398372
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay.
    Hildebrand-Zanki SU; Kern DH
    In Vitro Cell Dev Biol; 1986 May; 22(5):247-52. PubMed ID: 3710996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
    Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
    Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside composition of human melanoma and response to antitumor treatment.
    Kono K; Tsuchida T; Kern DH; Irie R
    Cancer Invest; 1990; 8(2):161-7. PubMed ID: 2400937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.
    Zaffaroni N; Silvestrini R; Grignolio E; Villa R; DeMarco C
    Int J Cell Cloning; 1988 Nov; 6(6):392-403. PubMed ID: 2466088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
    Bénard J; Riou G
    Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.